hemoglobin news

All news on hemoglobin (also known as Hgb): plants, production capacities, investments and involved companies.

24 August 2026

Johnson & Johnson's IMAAVY approved by FDA as first therapy for warm autoimmune hemolytic anemia

FDA cleared therapy for wAIHA in patients ≥12 previously or currently treated with corticosteroids; showed rapid hemoglobin gains and durable responses in Phase 2/3 ENERGY.
11 June 2026

Johnson & Johnson’s IMAAVY shows rapid, durable hemoglobin gains in Phase 2/3 wAIHA trial

Nipocalimab 30 mg/kg produced rapid hemoglobin rises and ~3× more durable responders versus placebo at 24 weeks, with early fatigue improvement and reduced steroid use.

Who will be producing hemoglobin in the future?

Find out with chemXplore Alpha

Learn more